Induction Healthcare Group PLC Block listing Interim Review (7796H)
July 31 2023 - 10:13AM
UK Regulatory
TIDMINHC
RNS Number : 7796H
Induction Healthcare Group PLC
31 July 2023
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Block Listing Six Monthly Return
Induction Healthcare (AIM: INHC), a leading digital health
platform driving transformation of healthcare systems, makes the
six monthly update on its block listing pursuant to AIM Rule 29 and
Schedule 6 of the AIM Rules for Companies below. The Company has
identified an error in the six monthly update to 26 July 2022,
announced on 27 July 2022, which incorrectly detailed 396,567
ordinary shares as having been issued and allotted when it should
have been 329,573 ordinary shares. As such, the number of ordinary
shares still to be issued and allotted is 3,170,427 and not
3,103,433 as previously incorrectly disclosed.
Name of applicant: Induction Healthcare Group PLC
LEI: 213800RY96GCZQW5TP19
Name of scheme: The Induction Healthcare NTA Share
Option Plan
-------------------------------------------
Period of return: From: 27/01/2023 To: 26/07/2023
-------- ------------ ------ -----------
Number and class of securities 3,500,000 ordinary shares on 26 July
originally admitted and the date 2021
of admission
-------------------------------------------
Balance of unallotted securities
under scheme(s) from initial
application: 3,170,427
-------------------------------------------
Plus: The amount by which the Nil
block scheme(s) has been increased
since the date of the last return
(if any increase has been applied
for):
-------------------------------------------
Less: Number of securities issued/allotted Nil
under scheme(s) during the period:
-------------------------------------------
Equals: Balance under scheme(s)
not yet issued/allotted at end
of period: 3,170,427
-------------------------------------------
Contact: Louise Torr, Company Secretary
louise.t@inductionhealthcare.com
-------------------------------------------
Enquiries
Induction
Christopher Samler, Chair +44 (0)7712 194092
Paul Tambeau, Chief Executive Officer +44 (0)7983 104443
Singer Capital Markets (Nominated
Adviser and Broker) +44 (0)20 7496 3000
Philip Davies
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software
solutions that transforms care delivery and the patient journey
through hospital. Our system-wide applications help healthcare
providers and administrators to deliver care at any stage remotely
as well as face-to-face - giving the communities they serve greater
flexibility, control and ease of access. Purpose-built for
integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as
well non-health government services, our applications are relied
upon by hundreds of thousands of clinicians and millions of
patients across almost every hospital in the British Isles.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRWPUBUMUPWGCG
(END) Dow Jones Newswires
July 31, 2023 10:13 ET (14:13 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024